BSE Circulars (18441)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FRIEZA 06 2025 PTCs will undergo part redemption with reduced face value from Rs. 0.60 per PTC effective January 1, 2026. | |||||||||||||||
FRIEZA 06 2025 PTCs will undergo part redemption with reduced face value from Rs. 0.60 per PTC effective January 1, 2026.
| |||||||||||||||
BSE revises price bands for 22 scrips including Swiggy, Waaree Energies, Premier Energies, Bajaj Holdings, and others, effective from … | |||||||||||||||
BSE revises price bands for 22 scrips including Swiggy, Waaree Energies, Premier Energies, Bajaj Holdings, and others, effective from December 31, 2025.
| |||||||||||||||
BSE announces revised price bands for 22 scrips including Swiggy, Waaree Energies, Premier Energies, and Bajaj Holdings & Investment, … | |||||||||||||||
BSE announces revised price bands for 22 scrips including Swiggy, Waaree Energies, Premier Energies, and Bajaj Holdings & Investment, effective from December 31, 2025.
| |||||||||||||||
BSE circular regarding allocation of equity shares to anchor investors in the public issue of Modern Diagnostic and Research Centre Limited. | |||||||||||||||
BSE circular regarding allocation of equity shares to anchor investors in the public issue of Modern Diagnostic and Research Centre Limited.
| |||||||||||||||
BSE circular regarding the allocation details for anchor investors in the public issue of Modern Diagnostic and Research Centre Limited. | |||||||||||||||
BSE circular regarding the allocation details for anchor investors in the public issue of Modern Diagnostic and Research Centre Limited.
| |||||||||||||||
BSE revokes the suspension in trading of equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension in trading of equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE revokes the trading suspension on equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing trading to resume. | |||||||||||||||
BSE revokes the trading suspension on equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing trading to resume.
| |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to … | |||||||||||||||
BSE revokes the suspension of trading in equity shares of Rekvina Laboratories Limited (Scrip Code: 526075), allowing normal trading to resume.
| |||||||||||||||
BSE announces trading in Rights Entitlements (REs) for Vineet Laboratories Limited from January 1, 2026 to January 16, 2026, with the rights … | |||||||||||||||
BSE announces trading in Rights Entitlements (REs) for Vineet Laboratories Limited from January 1, 2026 to January 16, 2026, with the rights issue opening January 1-21, 2026.
| |||||||||||||||